More on VRAX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (10/2/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Virax Biolabs Group (NQ:VRAX)
Delayed: 2.60 -0.22 (7.8%)
Prev. Close $2.82  
Open$2.82 
52 Wk High$ 
52 Wk Low$ 
Day High$2.84 
Day Low$2.56 
P/E N/A  
EPS$ 
Volume86,170 

Friends, Peers and Foes (?): NASDAQ-VRA, AVLNF, AENT RNAZ (more...)

Aug 26, 2026 04:30 PM Form 6-K Virax Biolabs Group Ltd For: Aug 21
Aug 20, 2026 10:00 AM Join Virax's Live Investor Webinar: Advancing Immune Diagnostics, Clinical Development and Commercial Execution
Aug 18, 2026 07:31 AM Form 6-K Virax Biolabs Group Ltd For: Aug 18
Aug 7, 2026 09:01 AM Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Jul 31, 2026 07:45 AM Form 6-K Virax Biolabs Group Ltd For: Jul 31
Jul 24, 2026 04:21 PM Form F-3 Virax Biolabs Group Ltd
Jul 20, 2026 09:01 AM Alliance Entertainment and Virax Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Jul 16, 2026 07:32 AM Form 6-K Virax Biolabs Group Ltd For: Jul 16
Jul 16, 2026 07:30 AM Virax Biolabs reports cash of $6.4M, regains Nasdaq compliance
Jul 16, 2026 07:30 AM Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement
View All Articles

Entities mentioned with VRAX

View All Entities